The co-administration of indiplon (NBI-34060) and alcohol lacks pharmacokinetic and pharmacodynamic interactions

被引：0
|
作者：
Berkowitz, DW
Scharf, MB
Jochelson, P
Oliva, J
Boyd, M
Kean, Y
Campbell, B
机构：
[1] Tri State Sleep Disorders Ctr, Cincinnati, OH USA
[2] Neurocrine Biosci Inc, San Diego, CA USA
来源：
SLEEP | 2003年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A81 / A81
页数：1
相关论文
共 50 条
  • [1] Lack of pharmacological and pharmacokinetic tolerance following repeat dosing of indiplon (NBI-34060)
    Jochelson, P
    Chen, TK
    Farber, R
    Campbell, B
    SLEEP, 2003, 26 : A85 - A86
  • [2] The activity of modified release indiplon (NBI-34060) in a transient nighttime venipuncture model
    Jochelson, P
    Bozigian, H
    Garber, M
    Baron, C
    Boyd, M
    Burke, J
    Roth, T
    Campbell, B
    SLEEP, 2003, 26 : A84 - A84
  • [3] Safety and efficacy of immediate release indiplon (NBI-34060) in elderly patients with insomnia
    Scharf, MB
    Rosenberg, R
    Cohn, M
    Zammit, G
    Rogowski, R
    Jochelson, P
    Farber, R
    Burke, J
    Campbell, B
    SLEEP, 2003, 26 : A85 - A85
  • [4] Efficacy and tolerability of indiplon (NBI-34060) solution in healthy adults in a model of transient insomnia
    Roth, T
    Walsh, JK
    Rogowski, R
    Farber, R
    Burke, J
    Jochelson, P
    SLEEP, 2003, 26 : A87 - A87
  • [5] In vitro metabolism of NBI-34060 (indiplon) and its potential to inhibit P450 enzymes
    Fisher, D
    Yuan, Z
    Jin, LP
    Sai, Y
    Madan, A
    Chapman, D
    Campbell, B
    Bozigian, HP
    DRUG METABOLISM REVIEWS, 2002, 34 : 171 - 171
  • [6] Efficacy and tolerability of four doses of indiplon (NBI-34060) modified-release in elderly patients with sleep maintenance insomnia
    Walsh, JK
    Lankford, DD
    Krystal, A
    Roth, T
    Jochelson, P
    Garber, M
    Alexander, T
    Burke, J
    SLEEP, 2003, 26 : A78 - A78
  • [7] NBI-34060 (a non-benzodiazepine sedative-hypnotic): Lack of a pharmacokinetic gender effect
    Rogowski, R
    Garber, M
    Bozigian, H
    Jochelson, P
    Farber, R
    Campbell, B
    SLEEP, 2002, 25 : A415 - A415
  • [8] Indiplon and SSRIs: Lack of pharmacodynamic and pharmacokinetic interactions
    Abdulnabi, R
    Janiczek, N
    Corrigan, B
    Hershberger, E
    Farber, R
    JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 45 (09): : 1077 - 1077
  • [9] Co-administration of liraglutide with insulin detemir demonstrates additive pharmacodynamic effects with no pharmacokinetic interaction
    Morrow, L.
    Hompesch, M.
    Guthrie, H.
    Chang, D.
    Chatterjee, D. J.
    DIABETES OBESITY & METABOLISM, 2011, 13 (01): : 75 - 80
  • [10] The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects
    Sidhu, J
    Job, S
    Singh, S
    Philipson, R
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (02) : 191 - 199
12345